###### Strengths and limitations of this study

-   Cohort study of the world's first mandatory cardiac arrest registry presenting establishment and the first results.

-   Includes almost 15 000 cases of cardiac arrest.

-   Merging information from a lot of different ambulance services uncovers challenges related to the understanding of the different data definitions.

-   The Norwegian registry uses the national unique personal identifier number, and generalisability of the method might be limited.

Introduction and background {#s1}
===========================

Response, treatment and outcome after out-of-hospital cardiac arrest (OHCA) is an internationally recognised quality indicator for the emergency medical service (EMS).[@R1] The links in the chain-of-survival highlight both the time-sensitive nature of interventions and the concept that high quality in all stages of treatment is necessary to improve patient outcome.[@R2]

A population-based cardiac arrest registry allows systematic assessment of the various components and aspects of resuscitation care; early recognition of cardiac arrest, bystander cardiopulmonary resuscitation (CPR), handling of emergency calls, dispatch assisted CPR (DA-CPR), ambulance dispatch and care, and hospital treatment. Registry data may facilitate an understanding of how each element in a system affects survival and identify potential for improvement.[@R3]

The reported population incidence of OHCA in which CPR is initiated by a bystander or the EMS varies worldwide. A recent European study reports an incidence between 28 and 91 per 100 000 inhabitants.[@R4] The Australasian Resuscitation Outcomes Consortium (Aus-ROC) report similar estimates between 35 and 54 per 100 000 inhabitants.[@R5] The outcome after OHCA varies between and within countries. Sweden, establishing a voluntary registry already in 1990, reports the incidence of survival after OHCA between 3.7 and 10.4 per 100 000 inhabitants,[@R6] similar to prior publications from single centres in Norway.[@R7]

In 2013, Norwegian Cardiac Arrest Registry (NorCAR) became part of the Norwegian Cardiovascular Disease Registry (NCVDR) run by Norwegian Institute of Public Health and reporting to the registry became mandatory.

The aim of this paper is to describe how the inclusion rate, the incidence and estimated survival developed in this world's first mandatory, population-based cardiac arrest register over its first 6 years.

Methods {#s2}
=======

Setting {#s2-1}
-------

Norway has 5.3 million inhabitants with a population density that varies considerably between urban and rural areas (Oslo 223/km^2^; Finnmark 1.6/km^2^). The Norwegian single-payer public insurance covers all aspects of healthcare. Specialist healthcare is organised in 4 regional and 19 local Health Trusts. For medical emergencies, there is one dedicated medical emergency telephone number, 113, that terminates at 16 local Emergency Medical Communications Centres (EMCCs).

EMCCs are staffed with nurses and ambulance personnel, and dispatch the EMS. The EMS response may include ambulance, physician staffed helicopters/rapid response car, ambulance boats as well as first responders from the fire brigade and out-of-office-hours general practitioners, all dependent on the location of the arrest and the available resources. Telephone-guided first aid, including DA-CPR, has been an integrated EMCC routine since 1995. DA-CPR is provided to bystanders when the patient is unconscious and not breathing normally.

Data management and governance {#s2-2}
------------------------------

All residents in Norway are assigned an 11-digit unique personal identifier number. This ID is a common identifier across all public registries, including health systems and can be used by approved national registries to confirm data about birth, name, address and date of death. Provisional ID can be generated for temporary residents or when ID is unknown.

Registration of diseases and procedures related to cardiovascular conditions in NCVDR is regulated to allow the collection, analysis and use of sensitive data.[@R9] Reporting to NorCAR is mandatory as it is part of NCVDR, and there is no need for consent; rather all healthcare personnel and facilities have a duty to report. Through the online reporting system, the strictest level of patient privacy and data integrity is maintained in accordance with best practice and regulations.

Entry into NorCAR is made by data processors, often part-time nurses or paramedics with other tasks related to cardiac arrest education, organisation or quality improvement. All data processors are employed by the local Health Trusts. To ensure equal understanding of data definitions, data processors undergo standardised training and meet for yearly retraining and updates.

NorCAR is governed by a national advisory board representing all Regional Health Trusts, the Norwegian Resuscitation Council, the Norwegian Society of Cardiology, the Norwegian Myocardial Infarction Registry and the National Advisory Unit of Prehospital Emergency Medicine. The board also includes a data processor and a patient representative.

Patient and public involvement {#s2-3}
------------------------------

The user representative involved in this project is part of NorCARs steering committee. He represents the patient organisation National Association of Heart and Lung Disease that has 54 000 members across Norway suffering from cardiovascular diseases, including myocardial infarction, heart failure and stroke. He provides a channel for communication to the patient population as well as to the boards of health trusts through his network of fellow user representatives. He has been involved in the development of this research project.

Event registration {#s2-4}
------------------

All patients that are unresponsive without normal breathing, where bystander, first responders, EMS or other healthcare professionals initiate CPR or defibrillation, are included in the registry. DA-CPR is defined as treatment alongside basic or advanced CPR or defibrillation. Patients are included irrespective of having a confirmed cardiac arrest on EMS arrival or not. Patients who do not receive any CPR are not included, neither are newborns in need of resuscitation at birth.

Data sources {#s2-5}
------------

Registration of an event often starts in the EMCC when DA-CPR is initiated. After the event the attending ambulance personnel fill in a dedicated form and transfer the information to the data processor. The local data processors collects information on the event and the patient, checks data quality and collect additional information from the defibrillator and hospital records when applicable. To ensure compete local coverage, data processors routinely check for missing cases in the EMCC databases, air-ambulance patient report forms, hospital electronic records and the Norwegian Patient Registry. Several logical checks have been implemented in the electronic report form, preventing typing errors or non-logical entries and finally the national registry staff performs a second quality control of all submitted data.

Variables {#s2-6}
---------

The dataset in NorCAR adheres to the Utstein dataset and definitions,[@R10] with some minor modifications to adjust for local conditions, and include information on the event, treatment and outcome. A full description of our dataset can be found in the [online supplementary appendix](#SP1){ref-type="supplementary-material"}.
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Statistical methods {#s2-7}
-------------------

When calculating bystander CPR rates, all EMS witnessed cardiac arrests are excluded from the analysis. When calculating the incidence of ROSC and 30-day survival, only patients treated by EMS, or patients who have been successfully resuscitated using an Automatic External Defibrillator (AED) before EMS arrival, are included.

Descriptive measures are provided as mean with SD or median with range, as appropriate according to the distribution of data. For regions reporting part of a year, we calculate population incidence by dividing number of patients by the corresponding fraction of the person-years for that region. Yearly trends in the number of reported events, the population incidence and the incidence of survivors with 95% CIs were investigated using Poisson regression with year as predictor variable. Yearly trends in the prevalence of bystander CPR were investigated with logistic regression with year as predictor variable. A p\<0.05 was considered as statistically significant. The software R[@R11] was used for the statistical analyses.

Data protection {#s2-8}
---------------

NorCAR is a national person-identifiable health registry that does not require consent from the registered individual or next of kin.[@R9]

Results {#s3}
=======

Regional and national development since inception {#s3-1}
-------------------------------------------------

A total of 14 849 OHCA events were registered in NorCAR from 2013 to 2018. The number of participating health trusts rose steadily, and by May 2016 data collection and reporting was established in all of Norway ([figure 1](#F1){ref-type="fig"}).

![Map of Norway showing health trusts that report data to the National registry. Green: data collected the entire year, yellow: data collected for parts of the year, red: did not report.](bmjopen-2020-038133f01){#F1}

The reported number of OHCA per year increased from 1101 in 2013 to 3400 in 2018 ([figure 2](#F2){ref-type="fig"}, p\<0.01). The estimated population incidence also increased from 46 (95% CI 45 to 50) to 64 (62 to 66) per 100 000 inhabitants (p\<0.01). The incidence of OHCAs treated by ambulance increased from 44 to 53 per 100 000 inhabitants (p\<0.01). ([table 1](#T1){ref-type="table"})

![All patients included in the registry. Left axis and bars: number of out-of-hospital cardiac arrests treated by ambulance, by year of registration. Patients with EMS-observed collapse are identified as light grey. Right axis and lines: population incidence of ambulance treated arrests (blue), and population incidence of 30-day survival (green); per 100 000 inhabitants. EMS, emergency medical service.](bmjopen-2020-038133f02){#F2}

###### 

OHCA cases that receive attempted resuscitation included in the Norwegian cardiac arrest registry from 2013 to 2018

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                              2013          \%   Inc†   2014          \%   Inc†   2015          \%   Inc†   2016          \%   Inc†   2017          \%   Inc†   2018          \%   Inc†   All cases     \%   Inc†
  ------------------------------------------- ------------- ---- ------ ------------- ---- ------ ------------- ---- ------ ------------- ---- ------ ------------- ---- ------ ------------- ---- ------ ------------- ---- ------
  **Population covered**                      2370729            46     3395193            43     4793741            53     5220143            61     5295619            60     5312343            64     26387768           56

   No of patients                             1101                      1444                      2549                      3168                      3187                      3400                      14849              

   \                                          64 (54, 79)               65 (56, 79)               65 (55, 80)               64 (54, 78)               65 (54, 79)               65 (55, 79)               65 (55, 79)        
   Age\                                                                                                                                                                                                                      
   (median, 25th and 75th percentiles)                                                                                                                                                                                       

   Male gender                                749           68   32     972           67   29     1744          68   36     2100          66   40     2135          67   40     2222          65   42     9922          67   38

   Place of cardiac arrest home               695           63   29     897           62   26     1555          61   32     1884          59   36     1986          62   38     2129          63   40     9146          62   35

   Witnessed by bystander                     605           55   26     751           52   22     1312          51   27     1605          51   31     1656          52   31     1619          48   30     7548          51   29

   Witnessed by EMS                           155           14   6.5    162           11   4.8    329           13   6.9    389           12   7.5    401           13   7.6    356           10   6,7    1792          12   6,8

   Presumed cardiac cause                     882           80   37     1040          72   31     1752          69   37     2186          69   42     2183          68   41     2256          66   42     10299         69   39

  **No minus EMS witnessed**                  946                       1280                      2220                      2779                      2786                      3044                      13055              

   Bystander CPR                              719           76          1004          78          1691          76          2227          80          2277          82          2484          82          10402         80   

  **EMS treated**                             1038               44     1354               40     2320               48     2735               52     2731               52     2825               53     13003              49

   Initial shockable rhythm                   287           28   12     352           26   10     572           25   12     634           23   12     643           24   12     691           24   13     3179          24   12

   Sustained ROSC                             379           37   16     446           33   13     734           32   15     810           30   16     762           28   14     767           27   14     3898          30   15

   30-day survival                            190           18   8      182           13   5.4    361           16   7.5    375           14   7.2    368           13   6.9    402           14   7.6    1878          14   7.1

  **EMS treated + ROSC before EMS arrival**   1043               44     1362               40     2331               49     2753               53     2751               52     2846               54     13086              50

   30-day survival                            195           19   8.2    187           14   5.5    371           16   7.7    392           14   7.5    382           14   7.2    422           15   7.9    1949          15   7.4

  **Utstein comparator group\***              210                8.9    250                7.4    403                8.4    463                8.9    446                8.4    458                8.6    2230               8.5

   ROSC                                       138           66   5.8    158           63   4.7    236           59   4.9    259           56   5      260           58   4.9    255           56   4.8    1306          59   4.9

   30-day survival                            104           50   4.4    99            40   2.9    172           43   3.6    187           40   3.6    186           42   3.5    181           40   3.4    929           42   3.5

  **EMS witnessed with shockable rhythm**     49                 2.1    48                 1.4    84                 1.8    106                2      122                2.3    110                2.1    519                2

   ROSC                                       37            76   1.6    36            75   1.1    62            74   1.3    76            72   1.5    86            70   1.6    80            73   1.5    377           73   1.4

   30-day survival                            35            71   1.5    32            67   0.9    48            57   1      65            61   1.2    73            60   1.4    75            68   1.4    328           63   1.2

  **Resuscitated before EMS arrival (n)**     5                         8                         11                        18                        20                        21                        83                 

   30-day survival                            5                         5                         10                        17                        14                        20                        71                 
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Utstein comparator group including patients defibrillated before EMS arrival, and presenting with ROSC as first registered rhythm by EMS.

†Incidence of cardiac arrest per 100 000 inhabitants

CPR, cardiopulmonary resuscitation; EMS, emergency medical service; OHCA, out-of-hospital cardiac arrest.

Utstein comparator group {#s3-2}
------------------------

The Utstein comparator group of 2014[@R10] is defined as patients experiencing witnessed cardiac arrest where the first documented rhythm is shockable. In addition, we have included witnessed cardiac arrest-patients successfully resuscitated before EMS arrival to our Utstein comparator group. These patients have been defibrillated before EMS personnel arrive on scene and have spontaneous circulation when EMS arrives (shown as orange in [figure 3](#F3){ref-type="fig"}).

![The Utstein comparator group (witnessed collapse and shockable first rhythm). Left axis and bars: number of cardiac arrest patients by year of registration. Patients with EMS-observed collapse are identified as light grey. Patients successfully resuscitated with AED before EMS arrival are orange. Right axis and lines: population incidence of the total Utstein comparator group (including EMS witnessed cases and those resuscitated before EMS arrival) (blue line), and population incidence of 30-day survival in the total group (green); per 100 000 inhabitants. AED, Automatic External Defibrillator; EMS, emergency medical service.](bmjopen-2020-038133f03){#F3}

The incidence of the Utstein comparator group has varied between 7.4 and 8.9 per 100 000 inhabitants, with a survival incidence in this group of 3.5 per 100 000 inhabitants (42%). The incidence of ambulance witnessed cardiac arrests with shockable first rhythm has been about 2 per 100 000 inhabitants with a survival incidence of 1.2 per 100 000 inhabitants (63%). The survivors in the Utstein comparator group and ambulance witnessed arrests constitute more than 70% of the total number of 30-day survivors ([figure 3](#F3){ref-type="fig"}).

Patient demography and outcome {#s3-3}
------------------------------

Median age was 65 (IQR 55--79) years and 67% were male. In 80% of the cases, CPR was started before EMS arrival ([table 1](#T1){ref-type="table"}). Among the 13 003 ambulance treated patients, 15 per 100 000 inhabitants (30%) achieved return of spontaneous circulation (ROSC) that lasted long enough for hospital admission or for transferral to the next treating prehospital unit (sustained ROSC).

Likewise, 30-day survival was 7.1 per 100 000 inhabitants (14%) of the ambulance treated patients, and did not change over the period investigated (p=0.98). If we include patients defibrillated before EMS arrival, the overall survival is 7.4 per 100 000 inhabitants (15%).

Discussion {#s4}
==========

The main findings from the first 6 years of the world's first mandatory cardiac arrest registry was an initial increase in the reported incidence of OHCA, levelling off after a few years. We observed a stable incidence of survival at 30 days as well as a bystander CPR rate of 80% during the whole observation period. The likely explanation for the increasing number of events is a more complete registration.

The reported rate of bystander CPR of 80% is among the highest ever published.[@R4] It is not fully understood why Norway has such high bystander CPR rate, but DA-CPR being implemented in all EMCCs already in 1995, a culture of willingness to help as well as repeated CPR training in school and adult life gives our inhabitants knowledge of and a willingness to perform CPR. The historical background also includes the first ever resuscitation training manikin being 'born' in Norway in 1960.[@R12] The current public strategy to increase bystander CPR involves collaborations between the Norwegian Health Directorate, non-governmental organisations and EMCCs.[@R13] A study of the term 'Bystander CPR'[@R14] and an article from Aus-ROC[@R15] both underline the importance of clear definitions of what constitutes a 'bystander'. In the Norwegian registry, we have not seen any big changes in the rate of bystander CPR over the years, indication that the interpretation has not changed, and that the high bystander rates are representative for our nation.

The initial increases seen in total numbers and ambulance treated cardiac arrests per population at risk, has levelled off. We believe that this is due to an initial under-reporting of patients that were not treated by ambulance because they had clear signs of death, or the patient did not survive the event and was not transported to hospital. The stable survival rate at around 7 per 100 000 inhabitants, despite an increase in overall reported incidence, supports this. Reports from Denmark[@R16] and Sweden[@R17] indicate that survivors might also be under-reported to national registries, and a validation process of inclusions would further strengthen the registry.

As the number of included patients increase, the proportion of survivors decrease, again stressing the importance of reporting results as incidence rates in addition to percentages. Consistent method for reporting the number of cardiac arrests, compared with the number of inhabitants in the region covered, makes it possible to compare results across regions and between countries as suggested by Becker *et al*[@R18] Comparison of results can also be done for subgroups of patients, such as the Utstein Comparator group (witnessed and shockable first rhythm). As this group is more homogeneous in cause and treatment, percentages may be appropriate. In the Norwegian registry, ROSC rate and survival to 30 days in the Utstein comparator group were 59% and 42%, respectively. The ROSC rate is similar to the overall ROSC rate for this group in the EuReCa-two study, but the survival to 30 days is higher than reported both in the European study and in the Aus-ROC epistry.[@R4]

Some patients do not receive EMS treatment though bystanders have started CPR before ambulance arrival (12%, [table 1](#T1){ref-type="table"}). The reasons for EMS personnel not to start treatment can be signs of death, do-not-resuscitate-orders, further resuscitation is considered futile due to circumstances or comorbidities, or that the patient presents a pulse and signs of life on EMS arrival. Patients who have received bystander CPR, but have a pulse when EMS arrives, cannot be considered confirmed cardiac arrests. To be consistent and conservative, we do not include these patients when calculating survival with one exception; the patient has received a shock from an AED before EMS arrival. The number of reported patients in this group has increased from 5 in 2013 to more than 20, adding up to 83 patients over 6 years. The increase in the reported numbers could be due to a better reporting combined with increasing availability of AEDs in public places, use of first responders and the implementation of an AED-registry directly available in the maps in the EMCC.[@R13] It is, however, important to acknowledge that there are a lot of barriers to an increased use of AED and one such barrier is that the majority of cardiac arrests occurring at home (62%).

Limitations of the study {#s4-1}
------------------------

Collecting data from different local registries has resulted in some challenges related to the understanding of the different data definitions in the Utstein template. Translating the dataset and distributing it to all EMS personnel takes time, meaning that differences between Health Trusts the first years of the registry might be related to different interpretation of the definitions just as well as real differences. We hope that the continuous work from the registry, including standardised training and yearly meetings has contributed to a common interpretation. It is also unknown if the focus on treatment of OHCA has changed registration practices or if there is a changing culture.[@R18]

Missing information in the registry is handled by returning the registration to the relevant health trust, who then correct the data. Missing information that cannot be retrieved is handled by excluding the patient from the relevant analysis. It is, however, a challenge that by the time the national registry returns the form to the data processor, the cardiac arrest happened more than 3 months ago. Retrieving information more than 3 months after the event is difficult, and recall bias is substantial.

Conclusion {#s5}
==========

Having cardiac arrest as a reportable condition and closely following up all submitted registry data is essential when building a national registry. Defining cardiac arrest as a reportable condition made it possible to include all regions of Norway within a 4-year period, and increased the number of reported cardiac arrests cases to an incidence of 64 per 100 000 inhabitants. Survival to 30 days stayed stable with an incidence of 7.4 per 100 000 inhabitants.
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